CanChip revolutionizes cancer research with its cutting-edge tumor-on-a-chip technology, overcoming limitations in traditional models. By authentically replicating the tumor microenvironment, CanChip accelerates drug screening and cancer treatment development. Their expertise in designing tracheal tumor chips not only enhances efficiency and accuracy but also facilitates collaborations with universities, paving the way for personalized treatment strategies and marking a transformative chapter in the battle against cancer.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Am Mühlenberg 10, 14476, Potsdam,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.canchip.org
- Keywords
- 3D Cell culture, Genomics, Microfluidics, Tumor-on-Chip, Cancer-on-Chip, Organ-on-Chip, Simulation Of Metastasis, Microenvironment Interaction Studies, Drug Combination Screening, Biomarker Expression Profiling, Consulting Services.
- HQ
- Potsdam
Canchip Questions
Canchip's website is http://www.canchip.org
Canchip's LinkedIn profile is https://de.linkedin.com/company/canchip
Canchip has
6 employees.
View email and phone details for 6
employees at Canchip.
Canchip's industry is
Biotechnology Research
Canchip's top competitors are
Capreolos Gmbh,
Potsdam Science Park,
Edurino,
Preclinics Gmbh,
Fredis Kinderdusche,
Femote,
Sci-Bots Inc.,
Choco,
Proxima Fusion,
All About Midlife.
Canchip's categories are Biotechnology Research
Canchip's founding year is 2023
